PageSourceSearch

https://exit156.com/_next/static/chunks/1k30tp920u9f7.js?dpl=dpl_2nrx6sS756AS9rZQ4ZbWtYvqY1XV

js exit156.com collected 2026-10-07 09:45:40 UTC 62,612 bytes, 89 lines download raw bytes

1(globalThis.TURBOPACK||(globalThis.TURBOPACK=[])).push(["object"==typeof document?document.currentScript:void 0,98183,(e,t,i)=>{"use strict";Object.defineProperty(i,"__esModule",{value:!0});var n={assign:function(){return l},searchParamsToUrlQuery:function(){return r},urlQueryToSearchParams:function(){return o}};for(var a in n)Object.defineProperty(i,a,{enumerable:!0,get:n[a]});function r(e){let t={};for(let[i,n]of e.entries()){let e=t[i];void 0===e?t[i]=n:Array.isArray(e)?e.push(n):t[i]=[e,n]}return t}function s(e){return"string"==typeof e?e:("number"!=typeof e||isNaN(e))&&"boolean"!=typeof e?"":String(e)}function o(e){let t=new URLSearchParams;for(let[i,n]of Object.entries(e))if(Array.isArray(n))for(let e of n)t.append(i,s(e));else t.set(i,s(n));return t}function l(e,...t){for(let i of t){for(let t of i.keys())e.delete(t);for(let[t,n]of i.entries())e.append(t,n)}return e}},18967,(e,t,i)=>{"use strict";Object.defineProperty(i,"__esModule",{value:!0});var n={DecodeError:function(){return b},MiddlewareNotFoundError:function(){return v},MissingStaticPage:function(){return w},NormalizeError:function(){return x},PageNotFoundError:function(){return y},SP:function(){return m},ST:function(){return g},WEB_VITALS:function(){return r},execOnce:function(){return s},getDisplayName:function(){return u},getLocationOrigin:function(){return c},getURL:function(){return d},isAbsoluteUrl:function(){return l},isResSent:function(){return h},loadGetInitialProps:function(){return f},normalizeRepeatedSlashes:function(){return p},stringifyError:function(){return k}};for(var a in n)Object.defineProperty(i,a,{enumerable:!0,get:n[a]});let r=["CLS","FCP","FID","INP","LCP","TTFB"];function s(e){let t,i=!1;return(...n)=>(i||(i=!0,t=e(...n)),t)}let o=/^[a-zA-Z][a-zA-Z\d+\-.]*?:/,l=e=>o.test(e);function c(){let{protocol:e,hostname:t,port:i}=window.location;return`${e}//${t}${i?":"+i:""}`}function d(){let{href:e}=window.location,t=c();return e.substring(t.length)}function u(e){return"string"==typeof e?e:e.displayName||e.name||"Unknown"}function h(e){return e.finished||e.headersSent}function p(e){let t=e.split("?");return t[0].replace(/\\/g,"/").replace(/\/\/+/g,"/")+(t[1]?`?${t.slice(1).join("?")}`:"")}async function f(e,t){let i=t.res||t.ctx&&t.ctx.res;if(!e.getInitialProps)return t.ctx&&t.Component?{pageProps:await f(t.Component,t.ctx)}:{};let n=await e.getInitialProps(t);if(i&&h(i))return n;if(!n)throw Object.defineProperty(Error(`"${u(e)}.getInitialProps()" should resolve to an object. But found "${n}" instead.`),"__NEXT_ERROR_CODE",{value:"E1025",enumerable:!1,configurable:!0});return n}let m="u">typeof performance,g=m&&["mark","measure","getEntriesByName"].every(e=>"function"==typeof performance[e]);class b extends Error{}class x extends Error{}class y extends Error{constructor(e){super(),this.code="ENOENT",this.name="PageNotFoundError",this.message=`Cannot find module for page: ${e}`}}class w extends Error{constructor(e,t){super(),this.message=`Failed to load static file for page: ${e} ${t}`}}class v extends Error{constructor(){super(),this.code="ENOENT",this.message="Cannot find the middleware module"}}function k(e){return JSON.stringify({message:e.message,stack:e.stack})}},30747,e=>{"use strict";let t=[.16,1,.3,1],i={once:!0,margin:"-60px"};e.s(["EASE",0,t,"VIEWPORT",0,i,"fadeIn",0,{initial:{opacity:0,y:28},whileInView:{opacity:1,y:0},viewport:i,transition:{duration:.7,ease:t}},"riseIn",0,{initial:{opacity:0,y:40},whileInView:{opacity:1,y:0},viewport:i,transition:{duration:.8,ease:t}},"riseInDelay",0,e=>({initial:{opacity:0,y:40},whileInView:{opacity:1,y:0},viewport:i,transition:{duration:.8,ease:t,delay:e}})])},12637,e=>{"use strict";e.s(["INVESTOR_PORTAL_URL",0,"https://adfs4.sts.altareturn.com/adfs/ls/?wa=wsignin1.0&wtrealm=urn%3aportal%3aexit156&wctx=https%3a%2f%2fexit156.altareturn.com%2f_layouts%2f15%2fAuthenticate.aspx%3fSource%3d%252F&wreply=https%3a%2f%2fexit156.altareturn.com%2f_trust%2fdefault.aspx"])},66470,e=>{"use strict";var t=e.i(43476),i=e.i(46932),n=e.i(12637);let a="inline-flex items-center justify-center rounded-lg px-8 py-3.5 text-sm transition-all outline-none focus-visible:ring-2 focus-visible:ring-accent-fg/50 focus-visible:ring-offset-2 focus-visible:ring-offset-accent active:scale-95";e.s(["BottomCTA",0,function({id:e="contact",heading:r="Ready to Talk?",body:s="Whether you are a founder looking for a growth partner, a deal source with an opportunity, or an investor exploring the fund, we want to hear from you. Our process is direct. Our structure is simple. Our door is open.",primary:o={label:"Contact Us",href:"/contact-us"},secondary:l={label:"Access Investor Portal",href:n.INVESTOR_PORTAL_URL}}={}
1){return(0,t.jsx)("section",{id:e,"aria-labelledby":"contact-heading",className:"bg-accent px-6 py-28 text-accent-fg",children:(0,t.jsxs)(i.motion.div,{initial:{opacity:0,y:28},whileInView:{opacity:1,y:0},viewport:{once:!0,margin:"-60px"},transition:{duration:.7,ease:"easeOut"},className:"mx-auto flex max-w-2xl flex-col items-center text-center",children:[(0,t.jsx)("h2",{id:"contact-heading",className:"font-display text-5xl font-black uppercase tracking-tight sm:text-6xl",children:r}),(0,t.jsx)("p",{className:"mt-6 max-w-xl text-base leading-relaxed text-accent-fg/70",children:s}),(0,t.jsxs)("div",{className:"mt-10 grid w-full max-w-xs grid-cols-1 gap-3 sm:inline-grid sm:w-auto sm:max-w-none sm:grid-flow-col sm:auto-cols-fr",children:[(0,t.jsx)("a",{href:o.href,...o.href.startsWith("http")?{target:"_blank",rel:"noopener noreferrer"}:{},className:`${a} w-full bg-bg font-bold text-fg hover:scale-[1.03] hover:bg-bg/90`,children:o.label}),(0,t.jsx)("a",{href:l.href,...l.href.startsWith("http")?{target:"_blank",rel:"noopener noreferrer"}:{},className:`${a} w-full border border-accent-fg/30 font-medium text-accent-fg hover:border-accent-fg/60`,children:l.label})]})]})})}])},10542,35382,95420,e=>{"use strict";var t=e.i(60140),i=e.i(30551),n=e.i(86427),a=e.i(65566),r=e.i(71645),s=e.i(60830),o=e.i(87022);function l(e,t){let i,n=()=>{let{currentTime:n}=t,a=(null===n?0:n.value)/100;i!==a&&e(a),i=a};return o.frame.preUpdate(n,!0),()=>(0,o.cancelFrame)(n)}function c(e){return!("u"<typeof window)&&(e?(0,i.supportsViewTimeline)():(0,i.supportsScrollTimeline)())}var d=e.i(61327),u=e.i(83920),h=e.i(25791);let p=()=>({current:0,offset:[],progress:0,scrollLength:0,targetOffset:0,targetLength:0,containerLength:0,velocity:0}),f={x:{length:"Width",position:"Left"},y:{length:"Height",position:"Top"}};function m(e,t,i,n){let a=i[t],{length:r,position:s}=f[t],o=a.current,l=i.time;a.current=Math.abs(e[`scroll${s}`]),a.scrollLength=e[`scroll${r}`]-e[`client${r}`],a.offset.length=0,a.offset[0]=0,a.offset[1]=a.scrollLength,a.progress=(0,u.progress)(0,a.scrollLength,a.current);let c=n-l;a.velocity=c>50?0:(0,h.velocityPerSecond)(a.current-o,c)}e.i(47167);var g=e.i(44230),b=e.i(15923),x=e.i(76959),y=e.i(72846);let w={start:0,center:.5,end:1};function v(e,t,i=0){let n=0;if(e in w&&(e=w[e]),"string"==typeof e){let t=parseFloat(e);e.endsWith("px")?n=t:e.endsWith("%")?e=t/100:e.endsWith("vw")?n=t/100*document.documentElement.clientWidth:e.endsWith("vh")?n=t/100*document.documentElement.clientHeight:e=t}return"number"==typeof e&&(n=t*e),i+n}let k=[0,0],j=[[0,0],[1,1]],N={x:0,y:0},E=new WeakMap,S=new WeakMap,C=new WeakMap,A=new WeakMap,O=new WeakMap,T=e=>e===document.scrollingElement?window:e;function L(e,{container:t=document.scrollingElement,trackContentSize:i=!1,...n}={}){if(!t)return s.noop;let a=C.get(t);a||(a=new Set,C.set(t,a));let r=function(e,t,i,n={}){return{measure:t=>{!function(e,t=e,i){if(i.x.targetOffset=0,i.y.targetOffset=0,t!==e){let n=t;for(;n&&n!==e;)i.x.targetOffset+=n.offsetLeft,i.y.targetOffset+=n.offsetTop,n=n.offsetParent}i.x.targetLength=t===e?t.scrollWidth:t.clientWidth,i.y.targetLength=t===e?t.scrollHeight:t.clientHeight,i.x.containerLength=e.clientWidth,i.y.containerLength=e.clientHeight}(e,n.target,i),m(e,"x",i,t),m(e,"y",i,t),i.time=t,(n.offset||n.target)&&function(e,t,i){let{offset:n=j}=i,{target:a=e,axis:r="y"}=i,s="y"===r?"height":"width",o=a!==e?function(e,t){let i={x:0,y:0},n=e;for(;n&&n!==t;)if((0,y.isHTMLElement)(n))i.x+=n.offsetLeft,i.y+=n.offsetTop,n=n.offsetParent;else if("svg"===n.tagName){let e=n.getBoundingClientRect(),t=(n=n.parentElement).getBoundingClientRect();i.x+=e.left-t.left,i.y+=e.top-t.top}else if(n instanceof SVGGraphicsElement){let{x:e,y:t}=n.getBBox();i.x+=e,i.y+=t;let a=null,r=n.parentNode;for(;!a;)"svg"===r.tagName&&(a=r),r=n.parentNode;n=a}else break;return i}(a,e):N,l=a===e?{width:e.scrollWidth,height:e.scrollHeight}:"getBBox"in a&&"svg"!==a.tagName?a.getBBox():{width:a.clientWidth,height:a.clientHeight},c={width:e.clientWidth,height:e.clientHeight};t[r].offset.length=0;let d=!t[r].interpolate,u=n.length;for(let e=0;e<u;e++){let i=function(e,t,i,n){let a=Array.isArray(e)?e:k,r=0;
1return"number"==typeof e?a=[e,e]:"string"==typeof e&&(a=(e=e.trim()).includes(" ")?e.split(" "):[e,w[e]?e:"0"]),(r=v(a[0],i,n))-v(a[1],t)}(n[e],c[s],l[s],o[r]);d||i===t[r].interpolatorOffsets[e]||(d=!0),t[r].offset[e]=i}d&&(t[r].interpolate=(0,g.interpolate)(t[r].offset,(0,b.defaultOffset)(n),{clamp:!1}),t[r].interpolatorOffsets=[...t[r].offset]),t[r].progress=(0,x.clamp)(0,1,t[r].interpolate(t[r].current))}(e,i,n)},notify:()=>t(i)}}(t,e,{time:0,x:p(),y:p()},n);if(a.add(r),!E.has(t)){let e=()=>{for(let e of a)e.measure(o.frameData.timestamp);o.frame.preUpdate(i)},i=()=>{for(let e of a)e.notify()},n=()=>o.frame.read(e);E.set(t,n);let r=T(t);window.addEventListener("resize",n),t!==document.documentElement&&S.set(t,(0,d.resize)(t,n)),r.addEventListener("scroll",n),n()}if(i&&!O.has(t)){let e=E.get(t),i={width:t.scrollWidth,height:t.scrollHeight};A.set(t,i);let n=o.frame.read(()=>{let n=t.scrollWidth,a=t.scrollHeight;(i.width!==n||i.height!==a)&&(e(),i.width=n,i.height=a)},!0);O.set(t,n)}let l=E.get(t);return o.frame.read(l,!1,!0),()=>{(0,o.cancelFrame)(l);let e=C.get(t);if(!e||(e.delete(r),e.size))return;let i=E.get(t);E.delete(t),i&&(T(t).removeEventListener("scroll",i),S.get(t)?.(),window.removeEventListener("resize",i));let n=O.get(t);n&&((0,o.cancelFrame)(n),O.delete(t)),A.delete(t)}}let P=[[[[0,1],[1,1]],"entry"],[[[0,0],[1,0]],"exit"],[[[1,0],[0,1]],"cover"],[j,"contain"]],H={start:0,end:1};function I(e){if(!e)return{rangeStart:"contain 0%",rangeEnd:"contain 100%"};for(let[t,i]of P)if(function(e,t){let i=function(e){if(2!==e.length)return;let t=[];for(let i of e)if(Array.isArray(i))t.push(i);else{if("string"!=typeof i)return;let e=function(e){let t=e.trim().split(/\s+/);if(2!==t.length)return;let i=H[t[0]],n=H[t[1]];if(void 0!==i&&void 0!==n)return[i,n]}(i);if(!e)return;t.push(e)}return t}(e);if(!i)return!1;for(let e=0;e<2;e++){let n=i[e],a=t[e];if(n[0]!==a[0]||n[1]!==a[1])return!1}return!0}(e,t))return{rangeStart:`${i} 0%`,rangeEnd:`${i} 100%`}}let F=new Map;function M(e){let t={value:0},i=L(i=>{t.value=100*i[e.axis].progress},e);return{currentTime:t,cancel:i}}function V({source:e,container:t,...i}){let{axis:n}=i;e&&(t=e);let a=F.get(t);a||(a=new Map,F.set(t,a));let r=i.target??"self",s=a.get(r);s||(s={},a.set(r,s));let o=n+(i.offset??[]).join(",");return s[o]||(i.target&&c(i.target)?I(i.offset)?s[o]=new ViewTimeline({subject:i.target,axis:n}):s[o]=M({container:t,...i}):c()?s[o]=new ScrollTimeline({source:t,axis:n}):s[o]=M({container:t,...i})),s[o]}function W(e,{axis:t="y",container:i=document.scrollingElement,...n}={}){let a,r,o;if(!i)return s.noop;let d={axis:t,container:i,...n};return"function"==typeof e?function(e,t){return 2===e.length||t&&(t.target||t.offset)?L(i=>{e(i[t.axis].progress,i)},t):l(e,V(t))}(e,d):(a=V(d),r=d.target?I(d.offset):void 0,o=d.target?c(d.target)&&!!r:c(),e.attachTimeline({timeline:o?a:void 0,...r&&o&&{rangeStart:r.rangeStart,rangeEnd:r.rangeEnd},observe:e=>(e.pause(),l(t=>{e.time=e.iterationDuration*t},a))}))}var R=e.i(47414),_=e.i(74008);let z=()=>({scrollX:(0,n.motionValue)(0),scrollY:(0,n.motionValue)(0),scrollXProgress:(0,n.motionValue)(0),scrollYProgress:(0,n.motionValue)(0)}),B=e=>!!e&&!e.current;function $(e,i,n,a){return{factory:r=>{let s,o=()=>{B(n)||B(a)?t.microtask.read(o):s=W(r,{...i,axis:e,container:n?.current||void 0,target:a?.current||void 0})};return t.microtask.read(o),()=>{(0,t.cancelMicrotask)(o),s?.()}},times:[0,1],keyframes:[0,1],ease:e=>e,duration:1}}e.s(["useScroll",0,function({container:e,target:n,...s}={}){var o;let l=(0,R.useConstant)(z);o=s.offset,!("u"<typeof window)&&(n?(0,i.supportsViewTimeline)()&&!!I(o):(0,i.supportsScrollTimeline)())&&(l.scrollXProgress.accelerate=$("x",s,e,n),l.scrollYProgress.accelerate=$("y",s,e,n));let c=(0,r.useRef)(null),d=(0,r.useRef)(!1),u=(0,r.useCallback)(()=>(c.current=W((e,{x:t,y:i})=>{l.scrollX.set(t.current),l.scrollXProgress.set(t.progress),l.scrollY.set(i.current),l.scrollYProgress.set(i.progress)},{...s,container:e?.current||void 0,target:n?.current||void 0}),()=>{c.current?.()}),[e,n,JSON.stringify(s.offset)]);return(0,_.useIsomorphicLayoutEffect)(()=>
1{if(d.current=!1,!(B(e)||B(n)))return u();d.current=!0},[u]),(0,r.useEffect)(()=>{let i;if(!d.current)return;let r=()=>{let t=B(e),r=B(n);(0,a.invariant)(!t,"Container ref is defined but not hydrated","use-scroll-ref"),(0,a.invariant)(!r,"Target ref is defined but not hydrated","use-scroll-ref"),t||r||(i=u())};return t.microtask.read(r),()=>{(0,t.cancelMicrotask)(r),i?.()}},[u]),l}],10542);var J=e.i(37806);function q(e){let t=(0,R.useConstant)(()=>(0,n.motionValue)(e)),{isStatic:i}=(0,r.useContext)(J.MotionConfigContext);if(i){let[,i]=(0,r.useState)(e);(0,r.useEffect)(()=>t.on("change",i),[])}return t}function D(e,t){let i=q(t()),n=()=>i.set(t());return n(),(0,_.useIsomorphicLayoutEffect)(()=>{let t=()=>o.frame.preRender(n,!1,!0),i=e.map(e=>e.on("change",t));return()=>{i.forEach(e=>e()),(0,o.cancelFrame)(n)}}),i}e.s(["useMotionValue",0,q],35382);function U(e,t){let i=(0,R.useConstant)(()=>[]);return D(e,()=>{i.length=0;let n=e.length;for(let t=0;t<n;t++)i[t]=e[t].get();return t(i)})}e.s(["useTransform",0,function e(t,i,a,r){if("function"==typeof t){let e;return n.collectMotionValues.current=[],t(),e=D(n.collectMotionValues.current,t),n.collectMotionValues.current=void 0,e}if(void 0!==a&&!Array.isArray(a)&&"function"!=typeof i){var s=t,o=i,l=a,c=r;let n=(0,R.useConstant)(()=>Object.keys(l)),d=(0,R.useConstant)(()=>({}));for(let t of n)d[t]=e(s,o,l[t],c);return d}let d="function"==typeof i?i:function(...e){let t=!Array.isArray(e[0]),i=t?0:-1,n=e[0+i],a=e[1+i],r=e[2+i],s=e[3+i],o=(0,g.interpolate)(a,r,s);return t?o(n):o}(i,a,r),u=Array.isArray(t)?U(t,d):U([t],([e])=>d(e)),h=Array.isArray(t)?void 0:t.accelerate;return h&&!h.isTransformed&&"function"!=typeof i&&Array.isArray(a)&&r?.clamp!==!1&&(u.accelerate={...h,times:i,keyframes:a,isTransformed:!0,...r?.ease?{ease:r.ease}:{}}),u}],95420)},91994,e=>{"use strict";e.i(86427);var t=e.i(83352),i=e.i(83411),n=e.i(87022);function a(e){return"number"==typeof e?e:parseFloat(e)}var r=e.i(71645),s=e.i(37806),o=e.i(35382),l=e.i(95420);e.s(["useSpring",0,function(e,c={}){return function(e,c={}){let{isStatic:d}=(0,r.useContext)(s.MotionConfigContext),u=()=>(0,i.isMotionValue)(e)?e.get():e;if(d)return(0,l.useTransform)(u);let h=(0,o.useMotionValue)(u());return(0,r.useInsertionEffect)(()=>(function(e,r,s={}){let o,l=e.get(),c=null,d=l,u="string"==typeof l?l.replace(/[\d.-]/g,""):void 0,h=()=>{c&&(c.stop(),c=null),e.animation=void 0},p=()=>{(()=>{let i=a(e.get()),n=a(d);if(i===n)return h();let r=c?c.getGeneratorVelocity():e.getVelocity();h(),c=new t.JSAnimation({keyframes:[i,n],velocity:r,type:"spring",restDelta:.001,restSpeed:.01,...s,onUpdate:o})})(),e.animation=c??void 0,e.events.animationStart?.notify(),c?.then(()=>{e.animation=void 0,e.events.animationComplete?.notify()})};if(e.attach((e,t)=>{d=e,o=e=>{var i,n;return t((i=e,(n=u)?i+n:i))},n.frame.postRender(p)},h),(0,i.isMotionValue)(r)){let t=!0===s.skipInitialAnimation,i=r.on("change",i=>{var n,a,r,s;t?(t=!1,e.jump((n=i,(a=u)?n+a:n),!1)):e.set((r=i,(s=u)?r+s:r))}),n=e.on("destroy",i);return()=>{i(),n()}}return h})(h,e,c),[h,JSON.stringify(c)]),h}(e,{type:"spring",...c})}],91994)},8877,e=>{"use strict";var t=e.i(43476);e.s(["Eyebrow",0,function({children:e,className:i=""}){return(0,t.jsx)("p",{className:`font-din text-[0.65rem] font-bold uppercase tracking-[0.4em] text-accent ${i}`,children:e})}])},76599,e=>{"use strict";var t=e.i(43476),i=e.i(71645),n=e.i(46932),a=e.i(49652);let r={some:0,all:1};var s=e.i(98701);let o=[.16,1,.3,1],l={WebkitTextStroke:"2px var(--color-headline-outline)",color:"transparent"};e.s(["SplitHeadline",0,function({line1:e,line2:c,as:d="h2",align:u="left",reveal:h="scroll",baseDelay:p=0,className:f="",leadingClass:m="leading-[0.95]",id:g,style:b}){let{done:x}=(0,s.useIntro)(),y="block overflow-hidden pb-[0.05em]",w="intro"===h,v=(0,i.useRef)(null),k=function(e,{root:t,margin:n,amount:s,once:o=!1,initial:l=!1}={}){let[c,d]=(0,i.useState)(l);return(0,i.useEffect)(()=>{if(!e.current||o&&c)return;let i={root:t&&t.current||void 0,margin:n,amount:s};return function(e,t,{root:i,margin:n,amount:s="some"}={}){let o=(0,a.resolveElements)(e),l=new WeakMap,c=new IntersectionObserver(e=>
1{e.forEach(e=>{let i=l.get(e.target);if(!!i!==e.isIntersecting)if(e.isIntersecting){let i=t(e.target,e);"function"==typeof i?l.set(e.target,i):c.unobserve(e.target)}else"function"==typeof i&&(i(e),l.delete(e.target))})},{root:i,rootMargin:n,threshold:"number"==typeof s?s:r[s]});return o.forEach(e=>c.observe(e)),()=>c.disconnect()}(e.current,()=>(d(!0),o?void 0:()=>d(!1)),i)},[t,e,n,o,s]),c}(v,{once:!0,amount:.25}),j=w?x:k,N=e=>({initial:{y:"105%"},animate:j?{y:"0%"}:{y:"105%"},transition:{duration:w?1.3:1,ease:o,delay:e}});return(0,t.jsxs)(d,{ref:v,id:g,style:b,className:`font-display font-black uppercase tracking-tight text-fg ${m} ${"center"===u?"text-center":"right"===u?"text-right":"text-left"} ${f}`,children:[(0,t.jsx)("span",{className:y,children:(0,t.jsx)(n.motion.span,{className:"block text-balance",...N(p+.35*!!w),children:e})}),(0,t.jsx)("span",{className:y,children:(0,t.jsx)(n.motion.span,{className:"headline-ghost block text-balance",style:l,...N(p+(w?.62:.12)),children:c})})]})}],76599)},68877,e=>{"use strict";let t=(0,e.i(56420).default)("arrow-right",[["path",{d:"M5 12h14",key:"1ays0h"}],["path",{d:"m12 5 7 7-7 7",key:"xquz4c"}]]);e.s(["ArrowRight",0,t],68877)},3303,(e,t,i)=>{t.exports=e.r(79520)},49869,44695,e=>{"use strict";var t=e.i(43476);e.s(["HoneypotField",0,function(){return(0,t.jsxs)("div",{"aria-hidden":!0,className:"pointer-events-none absolute -left-[9999px] h-0 w-0 overflow-hidden opacity-0",children:[(0,t.jsx)("label",{htmlFor:"websiteConfirm",children:"Company website"}),(0,t.jsx)("input",{id:"websiteConfirm",name:"websiteConfirm",type:"text",tabIndex:-1,autoComplete:"off",defaultValue:""})]})}],49869),e.i(47167);var i=e.i(71645),n=e.i(3303);e.s(["TurnstileField",0,function({onToken:e,resetKey:a=0,theme:r="dark",className:s=""}){let o="0x4AAAAAAEEcMX3dE7wK80et",l=(0,i.useRef)(null),c=(0,i.useRef)(null),d=(0,i.useRef)(e);d.current=e;let[u,h]=(0,i.useState)(()=>!!window.turnstile),p=(0,i.useCallback)(()=>{o&&window.turnstile&&l.current&&(c.current&&(window.turnstile.remove(c.current),c.current=null),l.current.innerHTML="",d.current(""),c.current=window.turnstile.render(l.current,{sitekey:o,theme:r,callback:e=>d.current(e),"expired-callback":()=>d.current(""),"error-callback":()=>d.current("")}))},[o,r]);return(0,i.useEffect)(()=>{if(o&&u)return p(),()=>{c.current&&window.turnstile&&(window.turnstile.remove(c.current),c.current=null)}},[o,u,a,p]),(0,t.jsxs)("div",{className:s,children:[(0,t.jsx)(n.default,{src:"https://challenges.cloudflare.com/turnstile/v0/api.js?render=explicit",strategy:"afterInteractive",onLoad:()=>h(!0)}),(0,t.jsx)("div",{ref:l})]})}],44695)},45197,e=>{"use strict";var t=e.i(43476);e.s(["PlaceholderImage",0,function({asset:e,label:i,alt:n,ratio:a,rounded:r="rounded-2xl",className:s="",children:o}){return(0,t.jsxs)("div",{"data-asset":e,role:"img","aria-label":n,className:`relative flex items-center justify-center overflow-hidden border border-dashed border-border-strong bg-surface ${r} ${a??""} ${s}`,children:[(0,t.jsx)("span",{className:"pointer-events-none select-none px-4 text-center text-[0.6rem] font-bold uppercase tracking-[0.3em] text-fg/35",children:i}),o]})}])},76462,e=>{"use strict";var t=e.i(43476),i=e.i(57688),n=e.i(22016),a=e.i(46932),r=e.i(68877),s=e.i(45197),o=e.i(30747);e.s(["PostCard",0,function({slug:e,title:l,excerpt:c,category:d,date:u,image:h,imageAlt:p,delay:f=0}){return(0,t.jsx)(a.motion.li,{initial:{opacity:0,y:28},whileInView:{opacity:1,y:0},viewport:o.VIEWPORT,transition:{duration:.55,ease:o.EASE,delay:f},children:(0,t.jsxs)(n.default,{href:`/news/${e}`,className:"group flex h-full flex-col overflow-hidden rounded-2xl border border-border bg-bg transition-colors duration-300 hover:border-border-strong",children:[h?(0,t.jsx)("div",{className:"relative aspect-[16/9] w-full overflow-hidden border-b border-border bg-surface",children:(0,t.jsx)(i.default,{src:h,alt:p||l,fill:!0,className:"object-cover transition-transform duration-700 group-hover:scale-[1.03]",sizes:"(max-width: 640px) 100vw, (max-width: 1024px) 50vw, 33vw"})}):(0,t.jsx)(s.PlaceholderImage,{asset:`POST THUMBNAIL: ${l}`,label:"Post Thumbnail",alt:`Thumbnail image for: ${l}`,ratio:"aspect-[16/9]",rounded:"rounded-none",className:"border-0 border-b border-border"}),(0,t.jsxs)("div",{className:"flex flex-1 flex-col p-7 sm:p-8",children:[(0,t.jsx)("p",{className:"mb-3 text-[0.65rem] font-bold uppercase tracking-[0.22em] text-accent",children:d}),(0,t.jsx)("h3",{className:"mb-3 font-display text-xl font-black uppercase leading-snug tracking-tight text-fg sm:text-2xl",children:l}),(0,t.jsx)("p",{className:"mb-8 flex-1 text-sm font-bold leading-relaxed text-fg/70",children:c}),(0,t.jsxs)("div",{className:"mt-auto flex items-center justify-between gap-4 border-t border-border pt-5",children:[(0,t.jsx)("span",{className:"text-xs font-bold uppercase tracking-[0.18em] text-fg/40",children:u}),(0,t.jsxs)("span",{className:"inline-flex items-center gap-2 text-sm font-bold text-fg transition-colors group-hover:text-accent",children:["Read More",(0,t.jsx)(r.ArrowRight,{className:"h-3.5 w-3.5 transition-transform duration-300 group-hover:translate-x-1",strokeWidth:1.75,"aria-hidden":!0})]})]})]})]})})}])},31317,e=>{"use strict";let t=[{slug:"3-bold-predictions-for-health-systems-in-2025",title:"3 Bold Predictions for Health Systems in 2025",excerpt:"Epic's dominance is ending. Rural healthcare is reaching a breaking point. Consolidation is backfiring. Exit 156's take on where health systems are headed.",category:"Firm News",date:"June 18, 2025",image:"/blog-images/blog-image-1.png",imageAlt:"3 Bold Predictions for Health Systems in 2025",contentHtml:`<ol>
2<li>Epic's dominance is ending - The EHR giant will face disruption within the decade as nimble competitors and AI-driven solutions reshape the market.</li>
3<li>Rural healthcare is reaching a breaking point - Geographic and economic factors are creating barriers that could lock rural patients out of essential care.</li>
4<li>Consolidation is backfiring - While health systems merge for efficiency, smaller, specialized providers are proving they deliver better patient outcomes and innovation.</li>
5</ol>
6<h2>Epic Systems Will Be Replaced Within a Decade</h2>
7<p>Yes, we said it. Epic dominates the EHR market with a nearly 50% market share by bed count. Their integrated platform, billing reliability, and zero-customer-churn reputation have made them the darling of CEOs, CFOs, and CIOs. But here’s the catch: Epic’s strength is also its vulnerability. A monolithic codebase, high switching costs, and a customer focus that prioritizes executives over end users (clinicians, nurses, doctors) create a wide moat, but also a brittle one.</p>
8<p>Epic's platform is built on a single codebase. We believe that this archaic infrastru
8cture has an upper limit of capacity, eventually having to rebuild this codebase from the bottom-up. When this happens, Epic will be vulnerable to smaller, more nimble players that can iterate and adopt external trends with near immediate speed. Externally, as burnout rises and administrative burden erodes bedside care, the next wave of winners will be those who build for the daily user, not just the decision-maker. Emerging challengers are already here, such as:</p>
9<ul>
10<li><strong>Tali AI:</strong> Ambient voice assistant for clinicians.</li>
11<li><strong>Glass Health:</strong> AI-powered clinical reasoning and note generation.</li>
12<li><strong>Nexus Bedside:</strong> Virtual nursing to reduce burnout and staffing costs.</li>
13</ul>
14<p>These companies are lean, fast, and laser-focused on solving real pain points. The next EHR leader won’t just manage records - it will eliminate friction, automate the mundane, and empower clinicians.</p>
15<h2>The Healthcare Gap Is Widening - And Rural Patients Are Falling Through It</h2>
16<p>The barrier to healthcare access for rural populations is rising rapidly. Without swift innovation from companies and timely capital deployment from venture firms, rural communities risk being left behind.</p>
17<p>By 2030, all Baby Boomers will have reached retirement age. Coupled with rising chronic conditions and increasing hospital staff turnover, the healthcare system faces mounting pressure. As urban centers consolidate care and staffing shortages persist, rural providers are at risk of being outcompeted. Patients in these areas may be forced to travel long distances for care-discouraging routine visits and leading to worse long-term outcomes-or rely on telehealth, which requires reliable broadband access that many rural areas lack.</p>
18<p>The winners in this space will be those who can solve staffing shortages for rural providers or deliver scalable, accessible telehealth and mobile recovery solutions. Early challengers are already emerging, including:</p>
19<ul>
20<li><strong>Humla Health (backed by Exit 156 Capital):</strong> An innovative platform connecting nurses with healthcare facilities.</li>
21<li><strong>Axle Health:</strong> Online healthcare platform focused on in-home healthcare services.</li>
22<li><strong>MedArrive:</strong> Connects telemedicine with in-home healthcare services.</li>
23</ul>
24<p>Rural healthcare isn’t just underserved-it’s on the brink. If you're an investor, founder, or policymaker, the window to make a meaningful impact is closing fast. The next wave of healthcare innovation must prioritize access, equity, and scalability for rural communities.</p>
25<h2>Healthcare Consolidation is Reducing Care Quality - Smaller Care Providers Can Provide Massive Value</h2>
26<p>Both strategic and financial buyers are consolidating physician practices and regional hospitals at record pace, promising efficiency and cost savings. But here's the truth no one wants to admit: healthcare consolidation is eroding the very care relationships that drive better outcomes.</p>
27<p>The consolidation playbook is predictable: acquire, synergize and optimize for billing over care. But healthcare isn't manufacturing. When consolidation efforts cut access to certain services, patients lose access to the specialized care that drives better outcomes.</p>
28<p>The winners in healthcare's future won't be the largest systems-they'll be the smaller providers that are more connected to their patients. Independent practices and smaller health systems are nimble, responsive, and deeply connected to their communities. They adopt new technologies faster, pivot quickly, and maintain doctor-patient relationships proven to improve outcomes while reducing costs. Early leaders are already emerging:</p>
29<ul>
30<li><strong>Forward Health:</strong> Membership-based primary care operating focused, tech-enabled clinics.</li>
31<li><strong>One Medical:</strong> Network of small, efficient practices prioritizing convenience and patient satisfaction.</li>
32<li><strong>Carbon Health:</strong> Urgent care and primary care clinics that rapidly deploy new services without bureaucratic layers.</li>
33</ul>
34<p>The bottom line? Healthcare needs competition, not consolidation.</p>
35<p>The next wave of healthcare innovation won't come from creating bigger, more integrated systems. It will come from empowering smaller, more focused providers to deliver exceptional care in their communities.</p>`},{slug:"exit-156-featured-in-medical-alley",title:"Exit 156 featured in Medical Alley",excerpt:"Exit 156 and the Humla Health partnership covered by Medical Alley. A look at how the firm is transforming healthcare staffing.",category:"Press",date:"May 27, 2025",image:"/blog-images/blog-image-2.jpg",imageAlt:"Exit 156 featured in Medical Alley",contentHtml:`<p>Earlier this month, we shared our excitement about partnering with <a href="https://www.humla.com/" target="_blank" rel="noopener noreferrer">Humla Health</a> as they work to transform the future of healthcare staffing.</p>
36<p>In case you missed it, check out this feature from <a href="https://medicalalley.org/" target="_blank" rel="noopener noreferrer">Medical Alley</a>, which highlights why we believe Humla’s innovative approach is not only timely, but essential.</p>
37<p>The healthcare workforce is under pressure. Humla is building the infrastru
37cture to relieve it.</p>
38<p>📰 Read the full article:</p>
39<p><a href="https://medicalalley.org/exit-156-invests-in-humla-health-to-transform-the-future-of-healthcare-staffing/" target="_blank" rel="noopener noreferrer">https://medicalalley.org/exit-156-invests-in-humla-health-to-transform-the-future-of-healthcare-staffing/</a></p>`},{slug:"exit-156-invests-in-humla-health-to-transform-the-future-of-healthcare-staffing",title:"Exit 156 Invests in Humla Health to Transform Healthcare Staffing",excerpt:"New $2.0 million investment to accelerate growth of Humla Health, a tech-enabled nurse staffing platform connecting nurses and facilities.",category:"Investments",date:"May 13, 2025",image:"/blog-images/blog-image-3.png",imageAlt:"Exit 156 Invests in Humla Health to Transform Healthcare Staffing",contentHtml:`<p class="dateline"><strong>Sioux Falls, SD - May 13<sup>th</sup>, 2025</strong> - Exit 156 is excited to announce a $2.0 million investment in Humla Health, a fast-growing healthcare technology company reshaping how nurses and healthcare facilities connect. This strategic investment will complete Humla's Series A round and support their expansion into new markets, while further enhancing its seamless, fully digital nurse staffing platform.</p>
40<blockquote>"Humla Health is redefining what is possible in healthcare staffing," said Josh Robinson, Managing Partner at Exit 156. "Their platform offers a better way for nurses and facilities to connect, removing unnecessary friction and inefficiencies that have long plagued the industry. We believe Humla is building the future of healthcare labor and we’re excited to help them scale."</blockquote>
41<p>Founded to tackle the persistent challenges in healthcare staffing, Humla Health enables nurses to find and book open shifts directly through a user-friendly mobile app, bypassing costly and outdated staffing agencies, recruiters and other ‘middlemen’. The company is quickly gaining momentum with hospitals and health systems seeking faster, more cost-effective solutions to fill critical labor gaps.</p>
42<blockquote>"This partnership with Exit 156 is a big milestone for Humla," said Jessica Sylvester, CEO of Humla Health. "With their backing, we can accelerate our roadmap and grow our team. Most importantly, we can deepen our relationships with both healthcare systems and nurses, who are eager to create more streamlined access to each other, in a budget-friendly manner.</blockquote>
43<p>Humla is already operating in several key regions and plans to use the investment to expand its footprint, continue developing its proprietary platform, and hire top talent to support its mission of making healthcare staffing simple, fair, and transparent.</p>
44<h2>About Exit 156</h2>
45<p>Exit 156 is an investment firm focused on aligning distinctive, growth-oriented investment prospects with exceptional financial acumen and a network of operating partners. The firm specializes in small and middle-market businesses in healthcare services, devices, technology, and consumer goods.</p>
46<h2>About Humla Health</h2>
47<p>Humla Health is a technology-forward healthcare staffing company designed to give nurses and healthcare facilities more control, transparency, and efficiency in the shift-filling process. By replacing traditional staffing agencies with a modern, app-based, fully digital platform, Humla is creating a more connected, responsive, and cost-effective staffing ecosystem.</p>
48<p class="media-contact">For media inquiries, please contact:</p>
49<p>Josh Robinson  |\xa0<a href="mailto:[email protected]">[email protected]</a></p>`},{slug:"advancing-sepsis-detection-the-vsno-breath-analyzer",title:"Advancing Sepsis Detection: The VSNO Breath Analyzer",excerpt:"Vail Scientific's VSNO Breath Analyzer offers rapid, non-invasive sepsis screening in as little as two minutes, developed with Minnetronix Medical.",category:"Portfolio Updates",date:"April 29, 2025",image:"/blog-images/blog-image-4.jpg",imageAlt:"Advancing Sepsis Detection: The VSNO Breath Analyzer",contentHtml:`<p>𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗦𝗲𝗽𝘀𝗶𝘀 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗩𝗦𝗡𝗢™ 𝗕𝗿𝗲𝗮𝘁𝗵 𝗔𝗻𝗮𝗹𝘆𝘇𝗲r</p>
50<p>Sepsis is a life-threatening condition that demands rapid diagnosis and intervention. Traditional diagnostic methods can be slow and often require invasive blood draws.</p>
51<p>The VSNO™ Breath Analyzer by <a href="https://www.linkedin.com/company/vail-scientific-llc/" target="_blank" rel="noopener noreferrer">Vail Scientific, LLC</a>, developed in collaboration with <a href="https://www.linkedin.com/company/minnetronix-inc-/" target="_blank" rel="noopener noreferrer">Minnetronix Medical</a>
51, offers a non-invasive, portable, and rapid approach to screening for early signs of sepsis. Designed to analyze exhaled nitric oxide levels, the VSNO™ can deliver results in as little as two minutes, allowing healthcare teams to make faster, more informed decisions.</p>
52<p>Key features include:</p>
53<ul>
54<li>𝗖𝗼𝗺𝗽𝗮𝗰𝘁 𝗗𝗲𝘀𝗶𝗴𝗻: Redesigned to be 75% smaller than the previous prototype, making it easier to mount on IV poles for bedside use.</li>
55<li>𝗨𝘀𝗲𝗿-𝗙𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗜𝗻𝘁𝗲𝗿𝗳𝗮𝗰𝗲: Patients simply exhale into the device for quick, non-invasive analysis.</li>
56<li>𝗛𝗶𝗴𝗵 𝗦𝗲𝗻𝘀𝗶𝘁𝗶𝘃𝗶𝘁𝘆: Engineered to detect sepsis-related biomarkers at parts-per-billion levels, supporting earlier clinical insights.</li>
57</ul>
58<p>With sepsis remaining a leading cause of hospital deaths, innovations like the VSNO™ represent an important step forward in critical care technology. That's why <a href="https://www.linkedin.com/company/exit156/" target="_blank" rel="noopener noreferrer">Exit 156 Capital</a> is proud to partner with companies like Vail Scientific as they help to reshape the future of critical care.</p>
59<p>🔗 Learn more about this breakthrough innovation: <a href="https://www.designnews.com/medical/breath-based-sepsis-screening-vail-scientific-minnetronix-develop-portable-vsno-device" target="_blank" rel="noopener noreferrer">https://www.designnews.com/medical/breath-based-sepsis-screening-vail-scientific-minnetronix-develop-portable-vsno-device</a></p>`},{slug:"exit-156-capital-makes-first-strategic-investments-in-vail-scientific-and-clo-clo-foods",title:"Exit 156 Capital Makes First Strategic Investments in Vail Scientific and CLO-CLO Foods",excerpt:"Less than a year after launch, Exit 156 announces its first investments, backing Vail Scientific and CLO-CLO Foods.",category:"Investments",date:"April 18, 2025",image:"/blog-images/blog-image-5.png",imageAlt:"Exit 156 Capital Makes First Strategic Investments in Vail Scientific and CLO-CLO Foods",contentHtml:`<p>🚀 Less than a year after our launch, <a href="https://www.linkedin.com/company/exit156/" target="_blank" rel="noopener noreferrer">Exit 156 Capital</a> has announced its first investments, backing two companies with strong connections to the <a href="https://www.linkedin.com/company/csbsju/" target="_blank" rel="noopener noreferrer">College of Saint Benedict and Saint John’s University</a>. <a href="https://www.linkedin.com/in/joshrobinsoncxo/" target="_blank" rel="noopener noreferrer">Josh Robinson, CMA</a> (’06), <a href="https://www.linkedin.com/in/mikenathanmba/" target="_blank" rel="noopener noreferrer">Mike Nathan, MBA</a> (’97) and <a href="https://www.linkedin.com/in/brian-kueppers-1b6b84/" target="_blank" rel="noopener noreferrer">Brian Kueppers</a> (’89), deployed capital to <a href="https://www.linkedin.com/company/vail-scientific-llc/" target="_blank" rel="noopener noreferrer">Vail Scientific, LLC</a>, a health care diagnostics innovator, and <a href="https://www.linkedin.com/company/clo-clo-vegan-foods/" target="_blank" rel="noopener noreferrer">Clo-Clo Vegan Foods</a>, a fast-growing health food company.</p>
60<p>📣 These investments reflect the kind of purposeful innovation we’re proud to support, and we’re just getting started.</p>
61<p>🔗 Read the full article in the <a href="https://www.linkedin.com/company/minneapolis-st-paul-business-journal/" target="_blank" rel="noopener noreferrer">Minneapolis/St. Paul Business Journal (MSPBJ)</a>: <a href="https://www.bizjournals.com/twincities/news/2025/04/11/minnesota-based-exit-156-capital-makes-investments.html" target="_blank" rel="noopener noreferrer">https://www.bizjournals.com/twincities/news/2025/04/11/minnesota-based-exit-156-capital-makes-investments.html</a></p>`},{slug:"collaboration-fuels-success",title:"Collaboration Fuels Success",excerpt:"Josh Robinson of Exit 156 Capital and Wendy Hinnenkamp of CLO-CLO Foods sit down at Saint John's to talk entrepreneurship and the Johnnie-Bennie network.",category:"Firm News",date:"April 18, 2025",image:"/blog-images/blog-image-6.png",imageAlt:"Collaboration Fuels Success",contentHtml:`<p>Check out how alumni connections are driving business success!</p>
62<p>➡️ <a href="https://lnkd.in/gKQi_rX4" target="_blank" rel="noopener noreferrer">https://lnkd.in/gKQi_rX4</a></p>`},{slug:"new-investment-will-accelerate-the-growth-of-clo-clos-wellness-lifestyle-food-products",title:"New Investment Will Accelerate the Growth of CLO-CLO's Wellness & Lifestyle Food Products",excerpt:"Exit 156 announces a $1.0 million investment in CLO-CLO Foods to expand allergen-friendly, plant-based food products.",category:"Investments",date:"April 18, 2025",image:"/blog-images/blog-image-7.jpeg",imageAlt:"New Investment Will Accelerate the Growth of CLO-CLO's Wellness & Lifestyle Food Products",contentHtml:`<p class="dateline"><em><strong>Sioux Falls, SD - April 15, 2025</strong>
63</em> - Exit 156 is excited to announce a $1.0 Million investment in CLO-CLO Foods, a trailblazer in the health and wellness food industry, headquartered in the Minneapolis area. This investment will support CLO-CLO’s mission to expand its line of innovative, delicious, and accessible allergen-friendly foods, which include their signature vegetable-based, gluten-free pizza crusts.</p>
64<blockquote>“We are thrilled to partner with CLO-CLO Foods, a company leading the way in plant-based alternatives,” said Josh Robinson, Managing Partner at Exit 156. “Their unique approach to allergen-friendly foods has the potential to transform the way people think about plant-based eating, and we’re confident that this investment will help fuel their growth and increase access to these sustainable products.\xa0 CLO-CLO is poised to become a category-defining brand in the health and wellness food space.”</blockquote>
65<p>CLO-CLO Foods was founded by Augie and Wendy Hinnenkamp, a modern health and wellness food company whose personal experience with food restrictions for their daughter inspired them to create a brand that prioritizes allergen-friendly foods. With a focus on clean, functional, and convenient nutrition, CLO-CLO offers products that are not only plant-powered but also free from common allergens, making them a great choice for people with dietary restrictions.</p>
66<blockquote>
66“We are beyond excited to have Exit 156’s support as we scale our business and expand our reach,” said Wendy Hinnenkamp, Founder and CMO of CLO-CLO Foods. “This funding will allow us to accelerate product development and bring our innovative options to even more consumers who are looking for healthier and sustainable food choices.”</blockquote>
67<p><em>CLO-CLO Foods </em>is already gaining traction with wellness-conscious consumers, families with diet restrictions, and busy families alike. With thoughtfully sourced ingredients and culinary creativity at the heart of every product, the brand is aiming to elevate frozen pizzas and flatbreads to a whole new standard.</p>
68<h2>About Exit 156</h2>
69<p>Exit 156 is an investment firm focused on aligning distinctive, growth-oriented investment prospects with exceptional financial acumen and their network of operating partners. They specialize in small and middle-market businesses in healthcare services, devices, technology, and consumer goods.</p>
70<h2>About CLO-CLO Foods</h2>
71<p>CLO-CLO Foods is a women-owned food innovator and disruptive brand in the Wellness & Lifestyle Foods Industry.\xa0 CLO-CLO Foods was founded by Augie and Wendy Hinnenkamp after their daughter’s food restrictions led them to seek out healthy, allergen-free alternatives.</p>
72<p><strong>For media inquiries, please contact:</strong></p>
73<p>Josh Robinson | [email protected]</p>`},{slug:"new-technology-will-address-one-of-the-leading-causes-of-death-worldwide",title:"New Technology Will Address One of the Leading Causes of Death Worldwide",excerpt:"Exit 156 announces a $2.0 million investment in Vail Scientific to accelerate VSNO sepsis screening technology.",category:"Investments",date:"April 10, 2025",image:"/blog-images/blog-image-8.jpg",imageAlt:"New Technology Will Address One of the Leading Causes of Death Worldwide",contentHtml:`<p class="dateline"><strong><em>Sioux Falls, SD - February 18, 2025</em></strong> - Exit 156 is proud to announce a $2.0 Million investment in <a href="https://vailscientific.com/" target="_blank" rel="noopener noreferrer">Vail Scientific Inc.</a>,\xa0 a pioneering company based in Minneapolis, Minnesota developing a diagnostic tool for screening patients suspected of having sepsis as an aid in triage. This investment will accelerate Vail Scientific’s development of its groundbreaking VSNO™ technology, which allows for real-time, non-invasive, and point-of-care screening of patients suspected of having sepsis.</p>
74<p>Sepsis is a leading cause of death in hospitals globally and improved screening tools as part of patient triage can lead to earlier diagnosis. According to recent <a href="https://newsroom.uw.edu/news-releases/sepsis-associated-1-5-deaths-globally?utm_source=chatgpt.com" target="_blank" rel="noopener noreferrer">studies</a> in the Lancet, 1 in 5\xa0 deaths worldwide is linked to sepsis, and, according to the NIH,\xa0 nearly <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7381455/?utm_source=chatgpt.com" target="_blank" rel="noopener noreferrer">one quarter</a> of sepsis cases treated are hospital-acquired.</p>
75<blockquote>“We are excited to support Vail Scientific in its mission to transform healthcare,” said Josh Robinson, Managing Partner at Exit 156. “Their innovative and groundbreaking approach to rapid sepsis screening is set to be the new standard of care, and we’re confident this investment will significantly enhance patient care.”</blockquote>
76<p>Vail Scientific is on a mission to aid in the early screening of patients with suspected sepsis with its groundbreaking technology. By aiding in the rapid screening of sepsis as part of the patient triage, Vail’s innovation has the potential to enhance patient care through more rapid sepsis diagnosis. Now, with the support of Exit 156, Vail is accelerating its journey - expanding clinical trials, advancing toward FDA clearance and commercialization of this novel screening diagnostic tool.</p>
77<p>We are thrilled to partner with Exit 156 to take our technology to the next level,” said Tom Burke, CEO of Vail Scientific. “This funding will enable us to expand our clinical trials and bring to market faster and enhance patient care.”</p>
78<h2>About Exit 156</h2>
79<p>Exit 156 is an investment firm focused on aligning distinctive, growth-oriented investment prospects with exceptional financial acumen and their network of operating partners. They specialize in small and middle-market businesses in healthcare services, devices, and technology.</p>
80<h2>About Vail Scientific</h2>
81<p>Vail Scientific was established by four founders with over eight decades of combined industry experience in medical technology and healthcare. The company is pioneering the development of VSNO™ sepsis screening technology that hopes to provide rapid, non-invasive additional screen at the point of care, helping healthcare providers treat patients more quickly and effectively.</p>
82<p><strong>For media inquiries, please contact:</strong></p>
83<p>Josh Robinson | [email protected]</p>
84<hr />
85<p>The information contained herein may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements may be identified through the use of words such as “may”, "expects/excepted", "will", "anticipates", “allows”, "estimates", "believes", “provides” or by statements indicating certain actions "may", "could", "should" or "might" occur. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The information contained\xa0 herein was current as of the date prepared and we specifically disclaim any obligation to update any forward-looking statements, whether as a result of new information, future developments, or otherwise.</p>`},{slug:"saint-johns-university-alumni-launch-venture-capital-firm-to-support-the-next-generation-of-entrepreneurs",title:"Saint John's University Alumni Launch Venture Capital Firm to Support the Next Generation of Entrepreneurs",excerpt:"Three Saint John's alumni launch Exit 156 Capital. Covered by the Minneapolis / St. Paul Business Journal.",category:"Press",date:"April 10, 2025",image:"/blog-images/blog-image-9.jpg",imageAlt:"Saint John's University Alumni Launch Venture Capital Firm to Support the Next Generation of Entrepreneurs",contentHtml:`<h2>Saint John’s University alumni launch venture capital firm to supp
85ort “the next generation of entrepreneurs”</h2>
86<p>Want to learn more about Exit 156 Capital's origin story?</p>
87<p>➡️Check out our article in the Minneapolis / St. Paul Business Journal: <a href="https://www.bizjournals.com/twincities/news/2024/08/16/saint-johns-alumni-launch-venture-capital-firm.html" target="_blank" rel="noopener noreferrer">https://www.bizjournals.com/twincities/news/2024/08/16/saint-johns-alumni-launch-venture-capital-firm.html</a></p>`},{slug:"1-7-million-americans-are-impacted-by-sepsis-each-year",title:"1.7 Million Americans Are Impacted by Sepsis Each Year",excerpt:"Early detection can mean the difference between life and death. Why Exit 156 invested in Vail Scientific's vSNO sepsis screening device.",category:"Portfolio Updates",date:"March 26, 2025",image:"/blog-images/blog-image-10.png",imageAlt:"1.7 Million Americans Are Impacted by Sepsis Each Year",contentHtml:`<p class="lead"><strong>1.7 million Americans are impacted by sepsis each year - and early detection can mean the difference between life and death.</strong></p>
88<p>That’s why in February 2025 we announced our investment in <a href="https://www.linkedin.com/company/vail-scientific-llc/" target="_blank" rel="noopener noreferrer">Vail Scientific, LLC</a>, a company aiming to redefine how we detect and respond to sepsis. Their vSNO™ Sepsis Screening Device, developed in partnership with <a href="https://www.linkedin.com/company/minnetronix-inc-/" target="_blank" rel="noopener noreferrer">Minnetronix Medical</a>, is a major step toward faster, noninvasive sepsis detection - something that could transform patient outcomes.</p>
89<p>➡️ Curious about how this game-changing tech is coming to life? Check out the full story here: <a href="https://lnkd.in/gXAJ5iu9" target="_blank" rel="noopener noreferrer">https://lnkd.in/gXAJ5iu9</a></p>`}];t[0];let i=t.slice(1),n=t.slice(0,3);e.s(["CATEGORIES",0,["All","Investments","Press","Portfolio Updates","Firm News"],"gridPosts",0,i,"homepagePosts",0,n])},97745,e=>{"use strict";var t=e.i(43476),i=e.i(71645),n=e.i(57688),a=e.i(46932),r=e.i(10542),s=e.i(95420),o=e.i(91994),l=e.i(98701),c=e.i(8877),d=e.i(76599);e.s(["NewsHero",0,function(){let e=(0,i.useRef)(null),{done:u}=(0,l.useIntro)(),{scrollYProgress:h}=(0,r.useScroll)({target:e,offset:["start start","end start"]}),p=(0,s.useTransform)(h,[0,1],[0,220]),f=(0,o.useSpring)(p,{stiffness:600,damping:80,restDelta:.001}),m=(0,s.useTransform)(h,[0,1],[0,80]),g=(0,o.useSpring)(m,{stiffness:600,damping:80,restDelta:.001}),b=(0,s.useTransform)(h,[0,.6],[1,0]),x=(0,s.useTransform)(h,[0,1],[.62,.92]);return(0,t.jsxs)("section",{id:"hero",ref:e,"aria-label":"News",className:"relative h-screen overflow-hidden",children:[(0,t.jsx)(a.motion.div,{style:{y:f,willChange:"transform"},className:"absolute inset-x-0 -top-32 h-[calc(100%+220px)]",children:(0,t.jsx)(a.motion.div,{className:"h-full w-full",initial:{scale:1.06},animate:{scale:1},transition:{duration:4.5,ease:"easeOut"},children:(0,t.jsx)(n.default,{src:"/news-hero.jpg",alt:"Exit 156 Capital news and platform updates",fill:!0,className:"object-cover object-center",priority:!0,sizes:"100vw"})})}),(0,t.jsx)(a.motion.div,{style:{opacity:x},className:"absolute inset-0 bg-bg","aria-hidden":!0}),(0,t.jsxs)(a.motion.div,{style:{y:g,opacity:b},className:"relative z-10 flex h-full flex-col items-center justify-center px-6 py-24 text-center",children:[(0,t.jsx)(a.motion.div,{initial:{opacity:0}
89,animate:u?{opacity:1}:{opacity:0},transition:{duration:1.4,ease:"easeOut"},children:(0,t.jsx)(c.Eyebrow,{className:"mb-6",children:"The Latest"})}),(0,t.jsx)(d.SplitHeadline,{as:"h1",align:"center",reveal:"intro",line1:"Signals From",line2:"the Platform.",leadingClass:"leading-[0.85]",className:"mb-8 max-w-5xl text-[clamp(2.85rem,10vw,3.75rem)]",style:{fontFamily:"var(--font-din)"}}),(0,t.jsx)(a.motion.p,{initial:{opacity:0},animate:u?{opacity:1}:{opacity:0},transition:{duration:1.3,ease:"easeOut",delay:.9},className:"max-w-2xl text-base leading-relaxed text-fg/60",children:"Investment announcements, portfolio milestones, and updates from across the Exit 156 ecosystem."})]}),(0,t.jsx)(a.motion.div,{style:{opacity:b},className:"absolute bottom-6 left-1/2 z-10 -translate-x-1/2","aria-hidden":!0,children:(0,t.jsxs)(a.motion.div,{initial:{opacity:0},animate:u?{opacity:1}:{opacity:0},transition:{duration:1,ease:"easeOut",delay:1.6},className:"flex flex-col items-center gap-3",children:[(0,t.jsx)("span",{className:"text-[0.6rem] font-bold uppercase tracking-[0.4em] text-fg/35",children:"Scroll"}),(0,t.jsx)(a.motion.div,{animate:{scaleY:[1,.4,1],opacity:[.5,1,.5]},transition:{repeat:1/0,duration:2,ease:"easeInOut"},className:"h-10 w-px origin-top bg-gradient-to-b from-fg/50 to-transparent"})]})})]})}])},80425,e=>{"use strict";var t=e.i(43476),i=e.i(57688),n=e.i(22016),a=e.i(46932),r=e.i(68877),s=e.i(45197),o=e.i(30747);e.s(["FeaturedPostCard",0,function({slug:e,title:l,excerpt:c,category:d,date:u,image:h,imageAlt:p,featuredTag:f="Latest"}){return(0,t.jsx)(a.motion.div,{initial:{opacity:0,y:32},whileInView:{opacity:1,y:0},viewport:o.VIEWPORT,transition:{duration:.7,ease:o.EASE},children:(0,t.jsxs)(n.default,{href:`/news/${e}`,className:"group grid overflow-hidden rounded-2xl border border-border-strong bg-bg-alt transition-colors duration-500 hover:border-fg/20 lg:grid-cols-2",children:[h?(0,t.jsx)("div",{className:"relative aspect-[16/10] w-full overflow-hidden bg-surface lg:aspect-auto lg:min-h-[22rem]",children:(0,t.jsx)(i.default,{src:h,alt:p||l,fill:!0,className:"object-cover transition-transform duration-700 group-hover:scale-[1.03]",sizes:"(max-width: 1024px) 100vw, 50vw",priority:!0})}):(0,t.jsx)(s.PlaceholderImage,{asset:`FEATURED POST IMAGE: placeholder for featured article thumbnail, larger aspect ratio than standard grid cards, post: ${l}`,label:"Featured Post Image",alt:`Thumbnail image for: ${l}`,ratio:"aspect-[16/10]",rounded:"rounded-none",className:"h-full w-full border-0"}),(0,t.jsxs)("div",{className:"flex flex-col justify-center p-8 sm:p-12 lg:p-14",children:[(0,t.jsxs)("div",{className:"mb-6 flex flex-wrap items-center gap-x-4 gap-y-2",children:[(0,t.jsx)("span",{className:"text-[0.65rem] font-bold uppercase tracking-[0.28em] text-accent",children:f}),(0,t.jsx)("span",{className:"text-fg/20","aria-hidden":!0,children:"·"}),(0,t.jsx)("span",{className:"text-[0.65rem] font-bold uppercase tracking-[0.22em] text-fg/45",children:d})]}),(0,t.jsx)("h3",{className:"mb-5 font-display text-3xl font-black uppercase leading-[0.95] tracking-tight text-fg sm:text-4xl",children:l}),(0,t.jsx)("p",{className:"mb-10 max-w-lg text-base leading-relaxed text-fg/55",children:c}),(0,t.jsxs)("div",{className:"mt-auto flex items-center justify-between gap-4 border-t border-border pt-6",children:[(0,t.jsx)("span",{className:"text-xs font-bold uppercase tracking-[0.2em] text-fg/40",children:u}),(0,t.jsxs)("span",{className:"inline-flex items-center gap-2 text-sm font-bold text-fg transition-colors group-hover:text-accent",children:["Read More",(0,t.jsx)(r.ArrowRight,{className:"h-3.5 w-3.5 transition-transform duration-300 group-hover:translate-x-1",strokeWidth:1.75,"aria-hidden":!0})]})]})]})]})})}])},45151,e=>{"use strict";var t=e.i(43476),i=e.i(71645),n=e.i(46932),a=e.i(56420);let r=(0,a.default)("chevron-left",[["path",{d:"m15 18-6-6 6-6",key:"1wnfg3"}]]),s=(0,a.default)("chevron-right",[["path",{d:"m9 18 6-6-6-6",key:"mthhwq"}]]);var o=e.i(8877),l=e.i(76599);function c({categories:e,active:i,onChange:n,className:a=""}){return(0,t.jsx)("div",{role:"group","aria-label":"Filter posts by category",className:`flex gap-6 overflow-x-auto border-b border-border pb-0 [-ms-overflow-style:none] [scrollbar-width:none] [&::-webkit-scrollbar]:hidden sm:gap-8 ${a}`,children:e.map(e=>{let a=e===i;return(0,t.jsx)("button",{type:"button","aria-pressed":a,onClick:()=>n(e),className:`-mb-px shrink-0 border-b-2 px-0.5 pb-3 text-xs font-bold uppercase tracking-[0.18em] outline-none transition-colors focus-visible:ring-2 focus-visible:ring-fg/60 focus-visible:ring-offset-2 focus-visible:ring-offset-bg ${a?"border-accent text-fg":"border-transparent text-fg/45 hover:text-fg/75"}`,children:e},e)})})}var d=e.i(76462),u=e.i(31317),h=e.i(30747);e.s(["PostsSection",0,function(){let[e,a]=(0,i.useState)("All"),p="All"===e?u.gridPosts:u.gridPosts.filter(t=>t.category===e);return(0,t.jsxs)(t.Fragment,{children:[(0,t.jsx)("section",{id:"filter","aria-label":"Filter posts by category",className:"theme-light bg-bg px-6 pt-12 sm:pt-16",children:(0,t.jsx)("div",{className:"mx-auto max-w-6xl",children:(0,t.jsx)(c,{categories:[...u.CATEGORIES],active:e,onCh
89ange:a})})}),(0,t.jsx)("section",{id:"posts","aria-labelledby":"posts-heading",className:"theme-light bg-bg px-6 py-16 sm:py-24",children:(0,t.jsxs)("div",{className:"mx-auto max-w-6xl",children:[(0,t.jsxs)(n.motion.div,{initial:{opacity:0,y:24},whileInView:{opacity:1,y:0},viewport:h.VIEWPORT,transition:{duration:.6,ease:h.EASE},className:"mb-12",children:[(0,t.jsx)(o.Eyebrow,{className:"mb-4",children:"All Posts"}),(0,t.jsx)(l.SplitHeadline,{id:"posts-heading",line1:"From the",line2:"Newsroom.",className:"text-5xl sm:text-6xl"})]}),p.length>0?(0,t.jsx)("ul",{className:"grid grid-cols-1 gap-6 sm:grid-cols-2 lg:grid-cols-3",children:p.map((e,i)=>(0,t.jsx)(d.PostCard,{...e,delay:i%3*.08},e.slug))}):(0,t.jsx)("p",{className:"text-sm text-fg/45",children:"No posts in this category yet."}),(0,t.jsxs)("nav",{"aria-label":"Post pagination",className:"mt-14 flex items-center justify-center gap-2",children:[(0,t.jsxs)("span",{"aria-disabled":!0,className:"flex h-9 w-9 items-center justify-center rounded-lg border border-border-strong text-fg/25",children:[(0,t.jsx)(r,{className:"h-4 w-4","aria-hidden":!0}),(0,t.jsx)("span",{className:"sr-only",children:"Previous page"})]}),(0,t.jsx)("a",{href:"?page=1","aria-current":"page",className:"flex h-9 w-9 items-center justify-center rounded-lg border border-accent bg-accent text-sm font-bold text-accent-fg outline-none focus-visible:ring-2 focus-visible:ring-fg/60 focus-visible:ring-offset-2 focus-visible:ring-offset-bg",children:"1"}),(0,t.jsxs)("span",{"aria-disabled":!0,className:"flex h-9 w-9 items-center justify-center rounded-lg border border-border-strong text-fg/25",children:[(0,t.jsx)(s,{className:"h-4 w-4","aria-hidden":!0}),(0,t.jsx)("span",{className:"sr-only",children:"Next page"})]})]})]})})]})}],45151)},3351,e=>{"use strict";var t=e.i(43476),i=e.i(71645),n=e.i(46932),a=e.i(8877),r=e.i(76599),s=e.i(49869),o=e.i(44695),l=e.i(30747);e.s(["NewsletterCapture",0,function(){let[e,c]=(0,i.useState)(""),[d,u]=(0,i.useState)("idle"),[h,p]=(0,i.useState)(""),[f,m]=(0,i.useState)(""),[g,b]=(0,i.useState)(0),x=(0,i.useRef)(Date.now());async function y(t){if(t.preventDefault(),!e||"submitting"===d)return;let i=t.currentTarget,n=i.elements.namedItem("websiteConfirm")?.value??"";if(!f){p("Please complete the verification check and try again."),u("error");return}u("submitting"),p("");try{let t=await fetch("/api/newsletter",{method:"POST",headers:{"Content-Type":"application/json"},body:JSON.stringify({email:e,websiteConfirm:n,formStartedAt:x.current,turnstileToken:f})});if(!t.ok){let e=await t.json().catch(()=>null);p(e?.error||"Could not subscribe. Please try again."),u("error"),m(""),b(e=>e+1);return}u("success"),c(""),m(""),b(e=>e+1),x.current=Date.now()}catch{p("Could not subscribe. Please try again."),u("error"),m(""),b(e=>e+1)}}return(0,t.jsxs)("section",{id:"newsletter","aria-labelledby":"newsletter-heading",className:"relative bg-bg-deep px-6 py-24 sm:py-32",children:[("submitting"===d||"success"===d)&&(0,t.jsx)("div",{className:"fixed inset-0 z-[120] flex items-center justify-center bg-[#061319]/72 px-6 backdrop-blur-[2px]",role:"status","aria-live":"polite",children:(0,t.jsx)("div",{className:"w-full max-w-md rounded-2xl border border-white/12 bg-[#0B3C4F] px-8 py-10 text-center shadow-[0_24px_80px_rgb(6_19_25/0.55)] sm:px-10",children:"submitting"===d?(0,t.jsxs)(t.Fragment,{children:[(0,t.jsx)("p",{className:"font-display text-2xl font-black uppercase tracking-tight text-white sm:text-3xl",children:"Subscribing…"}),(0,t.jsx)("p",{className:"mt-3 text-sm font-bold leading-relaxed text-white/55",children:"One moment while we add you to the list."})]}):(0,t.jsxs)(t.Fragment,{children:[(0,t.jsx)("p",{className:"font-display text-3xl font-black uppercase tracking-tight text-white sm:text-4xl",children:"Thanks, you are subscribed."}),(0,t.jsx)("p",{className:"mt-4 text-base font-bold leading-relaxed text-white/70",children:"You will get investment announcements and portfolio updates in this inbox."}),(0,t.jsx)("button",{type:"button",onClick:()=>u("idle"),className:"mt-8 rounded-lg bg-accent px-6 py-3 text-sm font-bold text-accent-fg outline-none transition-colors hover:bg-accent/90 focus-visible:ring-2 focus-visible:ring-accent/50",children:"Close"})]})})}),(0,t.jsxs)("div",{className:"mx-auto grid max-w-6xl gap-12 lg:grid-cols-2 lg:items-end lg:gap-20",children:[(0,t.jsxs)(n.motion.div,{initial:{opacity:0,y:28},whileInView:{opacity:1,y:0},viewport:l.VIEWPORT,transition:{duration:.7,ease:l.EASE},children:[(0,t.jsx)(a.Eyebrow,{className:"mb-4",children:"Stay Informed"}),(0,t.jsx)(r.SplitHeadline,{id:"newsletter-heading",line1:"Stay",line2:"Informed.",className:"text-5xl sm:text-6xl lg:text-7xl"}),(0,t.jsx)("p",{className:"mt-6 max-w-md text-base leading-relaxed text-fg/55",children:"Get investment announcements and portfolio updates sent directly to your inbox."})]}),(0,t.jsxs)(n.motion.div,{initial:{opacity:0,y:28},whileInView:{opacity:1,y:0},viewport:l.VIEWPORT,transition:{duration:.7,ease:l.EASE,delay:.1},children:[(0,t.jsxs)("form",{onSubmit:y,className:"relative flex w-full flex-col gap-4",noValidate:!0,children:[(0,t.jsx)(s.HoneypotField,{}),(0,t.jsxs)("div",{className:"flex w-full flex-col gap-4 sm:flex-row sm:items-stretch",children:[(0,t.jsx)("label",{htmlFor:"newsletter-email",className:"sr-only",children:"Email address"}),(0,t.jsx)("input",{id:"newsletter-email",type:"email",required:!0,value:e,onCh
89ange:e=>c(e.target.value),placeholder:"[email protected]",disabled:"submitting"===d||"success"===d,className:"h-14 w-full flex-1 rounded-lg border border-border-strong bg-bg px-5 text-base text-fg outline-none placeholder:text-fg/35 focus-visible:border-accent focus-visible:ring-2 focus-visible:ring-accent/40 disabled:opacity-60"}),(0,t.jsx)("button",{type:"submit",disabled:"submitting"===d||"success"===d,className:"h-14 shrink-0 rounded-lg bg-accent px-10 text-base font-bold text-accent-fg transition-all outline-none hover:bg-accent/90 focus-visible:ring-2 focus-visible:ring-accent/70 focus-visible:ring-offset-2 focus-visible:ring-offset-bg active:scale-95 disabled:cursor-not-allowed disabled:opacity-60",children:"Subscribe"})]}),(0,t.jsx)(o.TurnstileField,{onToken:m,resetKey:g,theme:"dark"})]}),"error"===d&&h&&(0,t.jsx)("p",{className:"mt-3 text-sm font-bold text-red-300",role:"alert",children:h})]})]})]})}])}]);

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.